Literature DB >> 20094872

Potential therapeutic application of host defense peptides.

Lijuan Zhang1, Timothy J Falla.   

Abstract

Host defense peptides (HDPs) are relatively small, mostly cationic, amphipathic, and of variable length, sequence, and structure. The majority of these peptides exhibit broad-spectrum antimicrobial activity and often activity against viruses and some cancer cell lines. In addition, HDPs also provide a range of immunomodulatory activities related to innate immunity defense, inflammation, and wound healing. The development of these multi-faceted molecules and their bioactivities into clinically important therapeutics is being pursued using a number of different approaches. Here we review the role of HDPs in nature and application of this role to the development of novel therapeutics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20094872     DOI: 10.1007/978-1-60761-594-1_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides.

Authors:  Davor Juretić; Damir Vukičević; Dražen Petrov; Mario Novković; Viktor Bojović; Bono Lučić; Nada Ilić; Alessandro Tossi
Journal:  Eur Biophys J       Date:  2011-01-28       Impact factor: 1.733

Review 2.  Latarcins: versatile spider venom peptides.

Authors:  Peter V Dubovskii; Alexander A Vassilevski; Sergey A Kozlov; Alexey V Feofanov; Eugene V Grishin; Roman G Efremov
Journal:  Cell Mol Life Sci       Date:  2015-08-19       Impact factor: 9.261

Review 3.  Interplay between Candida albicans and the antimicrobial peptide armory.

Authors:  Marc Swidergall; Joachim F Ernst
Journal:  Eukaryot Cell       Date:  2014-06-20

4.  Investigating the effect of a single glycine to alanine substitution on interactions of antimicrobial peptide latarcin 2a with a lipid membrane.

Authors:  Grace Idiong; Amy Won; Annamaria Ruscito; Bonnie O Leung; Adam P Hitchcock; Anatoli Ianoul
Journal:  Eur Biophys J       Date:  2011-07-07       Impact factor: 1.733

5.  Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.

Authors:  Mohammed Akhter Hossain; Laure Guilhaudis; Agnes Sonnevend; Samir Attoub; Bianca J van Lierop; Andrea J Robinson; John D Wade; J Michael Conlon
Journal:  Eur Biophys J       Date:  2011-02-11       Impact factor: 1.733

6.  An Immunomodulatory Peptide Confers Protection in an Experimental Candidemia Murine Model.

Authors:  Camila G Freitas; Stella M F Lima; Mirna S Freire; Ana Paula C Cantuária; Nelson G O Júnior; Tatiane S Santos; Jéssica S Folha; Suzana M Ribeiro; Simoni C Dias; Taia M B Rezende; Patrícia Albuquerque; André M Nicola; César de la Fuente-Núñez; Robert E W Hancock; Octávio L Franco; Maria Sueli S Felipe
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

7.  A Bioengineered Human Skin Tissue for the Treatment of Infected Wounds.

Authors:  Christina L Thomas-Virnig; B Lynn Allen-Hoffmann
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-04       Impact factor: 4.730

8.  Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.

Authors:  Shariq A Khan; Paul L Fidel; Awdah Al Thunayyan; Sharon Varlotta; Timothy F Meiller; Mary Ann Jabra-Rizk
Journal:  J AIDS Clin Res       Date:  2013-03-05

9.  Antimicrobial peptides: utility players in innate immunity.

Authors:  Mark W Robinson; Andrew T Hutchinson; Sheila Donnelly
Journal:  Front Immunol       Date:  2012-10-25       Impact factor: 7.561

10.  Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation.

Authors:  Marc Torrent; David Pulido; M Victòria Nogués; Ester Boix
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.